PoRI Clinical Trial
Randomized Clinical Trial of (PoRI) Post-Stroke Hand Rehabilitation Device
1 other identifier
interventional
12
1 country
1
Brief Summary
This randomized clinical trial compares the Portable Rehabilitation Interface (PoRI) device for rehabilitation of hand motor function in post-stroke patients with conventional hand therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 5, 2026
CompletedFirst Posted
Study publicly available on registry
February 12, 2026
CompletedStudy Start
First participant enrolled
March 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2027
March 27, 2026
March 1, 2026
1.4 years
February 5, 2026
March 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Fugl-Meyer Assessment (FMA) score
Fugl-Meyer Assessment (FMA) score to assess function with a total score of 100 points. Higher scores mean better recovery, with 0-50 indicating severe impairment and 95-100 showing minimal impairment in motor function, guiding rehabilitation progress.
Baseline and Week 2-3
Box-and-Block Tests (BBT) score
A Box-and-Block Test (BBT) score is the total number of small blocks a person moves from one section of a divided box to another within 60 seconds. More blocks moved equals greater dexterity.
Baseline and Week 2-3
Visual Analog Scale (VAS) Pain score
The VAS pain scale is a tool for assessing pain intensity. Participants will be asked to mark a point on a 100 mm horizontal line that represents the intensity of their pain. This line has two endpoints: 0: No pain and 100: Worst possible pain imaginable. The distance from the "0" to the mark is measured in millimeters with the resulting number (0-100) being the VAS pain score
Baseline and Week 2-3
Short Form McGill Pain Questionnaire (sfMPQ) score
The sfMPQ is scored by summing the values of words that best describe a person's pain. The score ranges from 0 (no pain) to 45 (severe pain).
Baseline and Week 2-3
Mean Score Modified Ashworth Scale (MAS)
MAS used to assess spasticity level with total score range 0-4. Higher scores indicate more rigidity.
Baseline and Week 2-3
Secondary Outcomes (1)
Device usability and accessibility survey
Week 2-3
Study Arms (2)
Portable Rehabilitation Interface (PoRI) + Conventional Therapy
EXPERIMENTALParticipants will receive seven 20-minute sessions with the PoRI device within 10 days during the course of care in addition to conventional therapy (standard of care) for 1 hour per day, 5 days per week for 2 to 3 weeks.
Conventional Therapy
NO INTERVENTIONParticipants will receive 1 hour sessions, 5 days per week for 2 to 3 weeks using conventional therapy (standard of care)
Interventions
Handheld device known as the Portable Rehabilitation Interface (PoRI) that moves the hand of patients with sensorimotor hand dysfunction
Eligibility Criteria
You may qualify if:
- Between 2 days and a maximum of 2 months have passed since the stroke event
- /5 muscle strength
- Participants with paralysis or sensorimotor function problems of the fingers of one or both hands.
- Participants must be able to fit their hand comfortably into the device.
You may not qualify if:
- Less than 2 days or greater than 2 months have passed since the stroke event
- /5 muscle strength
- Vulnerable populations.
- Inability of fingers and wrist to stretch to neutral during passive range of motion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
Study Sites (1)
Yale New Haven Hospital's Inpatient Rehabilitation Unit
Milford, Connecticut, 06460, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Necolle Morgado-Vega
Yale University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 5, 2026
First Posted
February 12, 2026
Study Start
March 23, 2026
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
September 1, 2027
Last Updated
March 27, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share